-
Cotation en bourse
-
Trading
Where European Government Bonds meet the futureFixed Income derivativesLire la suiteTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLire la suiteEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLire la suiteEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Lire la suiteThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLire la suiteThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
About Euronext
Euronext strategic planInnovate for Growth 2027Lire la suiteShaping capital markets for future generations
Bell Ceremony pour accueillir la semaine européenne de la biotechnologie 2014 à Bruxelles
08/10/2014
Le 8 Octobre2014, Nathalie Moll, secretary general d'EuropaBio et Karin Baudin, Vice-présidente Technology Transfer InsermTransfert de ENTENTE PROJECTont ouvert les marchés européens d'Euronext avec une Bell Ceremony.
Les partenaires duprojet ENTENTE, de la Commission Européenne et d’EuropaBio ont annoncé les 2 événements qui ont lieu pendant la semaine européenne de la biotechnologie notamment la 5ème édition de l’Award « Most Innovative European Biotech SME Award » et« ENTENTE Life Sciences Investment Forum ».
Ruxandra Draghia-Akli, Directrice, Direction Santé, DG Recherche et Innovation,de la CommissionEuropéenne a clôturé la Bell Ceremony avec un discours.
Pour en savoir plus : www.biotechweek.org